Mesenchymal Stem Cell

Andrews Medicine and Celltex Therapeutics Corporation have announced the formation of Andrews Celltex Biologics, a new company focused on the development of biotechnology and stem cell research for the treatment of athletic injuries.

A speaker at the 2021 OARSI World Congress said that synovial mesenchymal stem cell injections can suppress cartilage loss in patients with progressive osteoarthritis. It was the top story in rheumatology last week.

Intra-articular injections of mesenchymal stem cells into the synovium may yield expression of a number of genes that inhibit progression of osteoarthritis, according to a speaker at the 2021 OARSI World Congress virtual meeting.

An FDA advisory committee voted 9-1 in favor of approval of the cell therapy remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease.

The FDA has established a pathway to marketing for Revascor, an investigational cell therapy used for the prevention of postimplantation mucosal bleeding in patients with end-stage chronic heart failure who require a left ventricular assist device.